For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the annual meeting of the American ...
Mar 13, 2025
0
0
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 inflammatory responses drive disease ...
MIS-C is a serious inflammatory shock that affects children. It can occur several weeks after a COVID infection and can be life-threatening. Until now, however, the precise cause of the condition was unknown.
Mar 12, 2025
0
100
A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, Cambridge researchers have found.
Mar 12, 2025
0
1
Skin cancer is the most common cancer in the United States and a significant health issue, with millions of non-melanoma cases and tens of thousands of melanomas diagnosed annually. Furthermore, treating skin cancer costs ...
Mar 12, 2025
0
0
COVID-19 affects hundreds of millions of people worldwide and is often associated with long-term neurological abnormalities. Common symptoms include the loss of taste and smell, dizziness, "brain fog", headache, confusion, ...
Mar 11, 2025
0
66
What if treating autoimmune diseases was as simple as regulating the acidity levels of parts of patients' cells? Genetic screening may have unlocked a path for treating the severe inflammation associated with many immune ...
Mar 11, 2025
0
8
New research from the University of Kentucky has earned a spot on the cover of the Journal of Neuroscience, highlighting a major challenge in spinal cord injury recovery.
Mar 11, 2025
0
0
For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H1-antihistamines, administration of the oral, highly selective Bruton's tyrosine kinase inhibitor, remibrutinib, results ...
Mar 11, 2025
0
0
New research from RCSI University of Medicine and Health Sciences has found that white blood cells which 'remember' past inflammatory events are quick to overreact, raising the risk of blood clots.
Mar 10, 2025
0
28
